Sequential Intravesical Gemcitabine and Docetaxel is an Alternative to Bacillus Calmette-Guérin for the Treatment of Intermediate-risk Non–muscle-invasive Bladder Cancer
Wei Shen Tan, Ian M. McElree, Facundo Davaro, Ryan L. Steinberg, Kelly K. Bree, Neema Navai, Colin P. Dinney, Michael A. O’Donnell, Roger Li, Ashish M. Kamat, Vignesh T. Packiam
Topics & Concepts
MedicineBladder cancerDocetaxelGemcitabineHazard ratioInternal medicineOncologyCystectomyUrologyCancerInterquartile rangeCystoscopySurgeryConfidence intervalUrinary systemBladder and Urothelial Cancer TreatmentsUrinary and Genital Oncology StudiesUrological Disorders and Treatments